Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall-naïve cohort

Movement Disorders

Volumn 31, Issue 12, 2016, Pages 1829-1836

  Lord, Sue ^a   Galna, Brook ^a   Yarnall, Alison J ^a   Coleman, Shirley ^b   Burn, David ^a   Rochester, Lynn ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

falls; Parkinson's disease; prognosis

Indexed keywords

AGED; ARTICLE; CLINICAL ASSESSMENT; COGNITION ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; FALLING; FEMALE; FOLLOW UP; GAIT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STANDING; SURVIVAL ANALYSIS; WALKING SPEED; ADULT; BODY EQUILIBRIUM; COMPLICATION; MIDDLE AGED; NEUROLOGIC GAIT DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ACCIDENTAL FALLS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSTURAL BALANCE; SEVERITY OF ILLNESS INDEX;

EID: 84993947033     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26742     Document Type: Article

References (42)

1. Allan LM, Ballard CG, Rowan EN, Kenny RA. Incidence and prediction of falls in dementia: a prospective study in older people. PLoS One 2009;4(5):e5521.
2. Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2008;23(5):631–640.
3. Canning CG, Sherrington C, Lord SR, et al. Exercise for falls prevention in Parkinson disease: a randomized controlled trial. Neurology 2015;84(3):304–312.
4. Chung KA, Lobb BM, Nutt JG, Horak FB. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010;75(14):1263–1269.
5. Henderson EJ, Lord SR, Brodie MA, et al. Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 2016;15(3):249–258.
6. Pickering RM, Grimbergen YA, Rigney U, et al. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord 2007;22(13):1892–1900.
7. Almeida LRS, Sherrington C, Allen NE, et al. Disability is an independent predictor of falls and recurrent falls in people with Parkinson's disease without a history of falls: a one-year prospective study. J Parkinson Dis 2015;5(4):855–864.
8. Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA. Predictors of future falls in Parkinson disease. Neurology 2010;75(2):116–124.
9. van der Marck MA, Klok MP, Okun MS, et al. Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson's disease. Parkinsonism Relat Disord 2014;20(4):360–369.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55(3):181–184.
11. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189–198.
12. Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 2013;80(3):276–281.
13. Yarnall AJ, Breen DP, Duncan GW, et al. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 2014;82(4):308–316.
14. Lord S, Galna B, Coleman S, Yarnall A, Burn D, Rochester L. Cognition and gait show a selective pattern of association dominated by phenotype in incident Parkinson's disease. Front Aging Neurosci 2014;6:249.
15. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23(15):2129–2170.
16. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the Movement Disorder Society Unified Parkinson's Disease Rating Scale: comparison with the Unified Parkinson's Disease Rating Scale. Mov Disord 2013;28(5):668–670.
17. Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol A Biol Sci Med Sci 1995;50A(1):M28–M34.
18. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007;22(8):1077–1092.
19. Nieuwboer A, Rochester L, Herman T, et al. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers. Gait Posture 2009;30(4):459–463.
20. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25(15):2649–2653.
21. Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med 2008;358(6):615–624.
22. Galna B, Lord S, Rochester L. Is gait variability reliable in older adults and Parkinson's disease?. Towards an optimal testing protocol. Gait Posture 2013;37(4):580–585.
23. Lord S, Galna B, Verghese J, Coleman S, Burn D, Rochester L. Independent domains of gait in older adults and associated motor and nonmotor attributes: validation of a factor analysis approach. J Gerontol A Biol Sci Med Sci 2013;68(7):820–827.
24. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53(4):695–699.
25. Wesnes K. Assessing cognitive function in clinical trials: latest developments and future directions. Drug Discov Today 2002;7(1):29–35.
26. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 1994;5(5):266–281.
27. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007;22(13):1901–1911.
28. Lamb SE, Jorstad-Stein EC, Hauer K, Becker C, & Prevention of Falls Network Europe and Outcomes Consensus Group. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc 2005;53(9):1618–1622.
29. Kass G. An exploratory technique for investigating large quantities of categorical data. J R Stat Soc Ser C Appl Stat 1980;29(2):119–127.
30. Paul SS, Canning CG, Sherrington C, Lord SR, Close JC, Fung VS. Three simple clinical tests to accurately predict falls in people with Parkinson's disease. Mov Disord 2013;28(5):655–662.
31. Duncan RP, Cavanaugh JT, Earhart GM, et al. External validation of a simple clinical tool used to predict falls in people with Parkinson disease. Parkinsonism Relat Disord 2015;21(8):960–963.
32. Morris ME, Iansek R, Matyas TA, Summers JJ. The pathogenesis of gait hypokinesia in Parkinson's disease. Brain 1994;117(pt 5):1169–1181.
33. Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms. Brain 1996;119(pt 2):551–568.
34. Galna B, Lord S, Burn DJ, Rochester L. Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype. Mov Disord 2015;30(3):359–367.
35. Mancini M, Horak FB, Zampieri C, Carlson-Kuhta P, Nutt JG, Chiari L. Trunk accelerometry reveals postural instability in untreated Parkinson's disease. Parkinsonism Relat Disord 2011;17(7):557–562.
36. Horak FB. Postural orientation and equilibrium: what do we need to know about neural control of balance to prevent falls? Age Ageing 2006;35(suppl 2):ii7–ii11.
37. Del Din S, Godfrey A, Rochester L. Validation of an accelerometer to quantify a comprehensive battery of gait characteristics in healthy older adults and Parkinson's disease: toward clinical and at home use [published online ahead of print 2015]. IEEE J Biomed Health Inform.
38. Kabeshova A, Launay CP, Gromov VA, et al. Falling in the elderly: do statistical models matter for performance criteria of fall prediction?. Results from two large population-based studies. Eur J Intern Med 2016;27:48–56.
39. Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci 2003;212(1-2):47–53.
40. Smulders K, Esselink RA, Weiss A, Kessels RP, Geurts AC, Bloem BR. Assessment of dual tasking has no clinical value for fall prediction in Parkinson's disease. J Neurol 2012;259(9):1840–1847.
41. Allcock LM, Rowan EN, Steen IN, Wesnes K, Kenny RA, Burn DJ. Impaired attention predicts falling in Parkinson's disease. Parkinsonism Relat Disord 2009;15(2):110–115.
42. Morris ME, Martin CL, Schenkman ML. Striding out with Parkinson disease: evidence-based physical therapy for gait disorders. Phys Ther 2010;90(2):280–288.